Anti-inflammatory use during surgery could improve cancer outcomes
The world’s first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve
Read more
The world’s first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve
Read moreA lot can happen in a year: more than 950 children aged under 18 will be diagnosed with cancer and
Read moreResearch from the University of Alberta is prompting doctors to re-examine how they treat patients with thyroid cancer in Alberta.
Read moreAn evolutionary model utilizing serial blood samples from patients with advanced colorectal cancer treated with anti-EGFR therapies in a phase
Read moreTriple negative breast cancer is the rarest, but also the most aggressive and hard to treat form of the disease.
Read moreMelanoma and liver cancer are becoming more widespread in Europe and the U.S. While both diseases progress very differently, they
Read moreMakers of a revolutionary cancer treatment asked to slash its ‘eye-watering’ cost NHS watchdog urges the makers of a revolutionary
Read moreCristina Sabliov, LSU Biological and Agricultural Engineering professor, and Tammy Dugas, professor in the LSU School of Veterinary Medicine’s Department
Read moreMONDAY, Aug. 27, 2018 — Individuals who experience parental cancer as children or adolescents have a higher risk of low
Read moreAdding another inhibitor to therapies that cut off a tumor’s access to blood vessels could be the key to helping
Read more